Beneficial effect of HCL-31D in murine models of endotoxaemia

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 364, Issue 3, 2001, Pages 213-219

  Chou, T C ^a   Li, C Y ^a   Wu, T M ^a   Tang, S T ^a   Lee, A R ^a   Ding, Y A ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Endotoxic shock; Factor ; HCL 31D; Inducible nitric oxide synthase; Lipopolysaccharide; Tumour necrosis; Vascular smooth muscle cells

Indexed keywords

GAMMA INTERFERON; HCL 31D; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INDUCTION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; RISK BENEFIT ANALYSIS; SEPTIC SHOCK; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DRUG INTERACTIONS; ENDOTOXEMIA; ENZYME INDUCTION; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLATELET AGGREGATION INHIBITORS; PROPANOLAMINES; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034878813     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100100438     Document Type: Article

References (27)

1. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP
2. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells
3. Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP
4. Alterations of nitric oxide synthase induction with aging and hypertension in rats
5. Mechanism of inhibition of platelet aggregation by HCL-31D
6. Effects of prostacyclin analogs on the synthesis of tissue factor, tumour necrosis factor-α and interleukin-1β in human monocytic THP-1 cells
7. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma
8. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice
9. Isoforms of nitric oxide synthase. Characterization and purification from different cell types
10. Studies on 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191). I. Cyclic 3′,5′-nucleotide phosphodiesterase (PDE) and the inhibitory effect of BL 191 on PDE in rat brain and heart
11. Induction of the types A and B tumor necrosis factor (TNF) receptors is independently transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors
12. Overproduction of nitric oxide in cytokine-mediated and septic shock
13. Cloned and expression macrophage nitric oxide synthase contrasts with the brain enzyme
14. Nitric oxide synthase: Aspects concerning structure and catalysis
15. Amelioration of chronic iletis by nitric oxide synthase inhibition
16. Nitric oxide: Physiology, pathophysiology, and pharmacology
17. Induction of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP
18. Adenosine and related carbocyclic nucleotide analogue selectively inhibit tumour necrosis factor-alpha production and protect mice against endotoxin challenge
19. Cellular and molecular regulation of tumour necrosis factor-alpha production by pentoxifylline
20. Alterations in nitric oxide production in various forms of circulatory shock
21. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia
22. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of indotoxin shock
23. Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA induction
24. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation
25. Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia
26. A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase
27. The high-output nitric oxide pathway: Role and regulation